Biotechnology Jobs

• Siena, Italy
• €124,500 – €207,500 pa
• Director

Provides advanced scientific expertise in safety evaluation and risk management for key oncology assets in clinical development, leading signal detection, benefit-risk assessment and regulatory safety submissions. Represents SERM on cross-functional clinical matrix teams, escalates emerging safety issues to governance bodies and mentors junior staff within a global matrix environment.

• Philadelphia Walnut Street
• US$95,700 – US$159,500 pa
• Mid-level

Mid-level individual contributor on GSK's Enterprise AI Forward Deployed Engineering team, embedded with business unit teams to prototype AI proofs of concept at a days-to-weeks cadence. Works under senior FDEs using AI coding assistants and multi-agent workflows as the default mode of building, then hands proven solutions off cleanly to Solutions Engineers for productionisation.

Claude Code · GitHub Copilot · Databricks AI Assistant +3

• Oxford
• On-site
• Permanent

Designs and executes stage-gated experiments in advanced genome technologies and next-generation plant transformation, developing new methods for genetic manipulation, plant regeneration and DNA/RNA delivery. Works within a multidisciplinary Oxford institute, contributing to publications and IP generation while collaborating with AI, automation and generative biology experts.

AI

• Oxford
• On-site
• Lead
• Permanent

Lead the design and deployment of AI, robotics and computer vision systems to accelerate plant transformation and tissue culture workflows. Provide plant science subject matter expertise within a matrixed team, build data pipelines for predictive ML models, and manage project plans while mentoring researchers and driving commercial translation.

• Greater Poland
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, benefit-risk assessment, regulatory periodic reports and RMPs, working within a global cross-functional matrix alongside Clinical Operations, Regulatory and Biostatistics. Distinct for its strong focus on pharmacovigilance governance, safety strategy and scientific writing.

ICH · GVP · CIOMS

• London
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, periodic regulatory reports, RMPs and benefit-risk assessments within a global cross-functional matrix, presenting complex safety issues to senior governance committees. Distinct for its blend of pharmacovigilance strategy, regulatory writing and matrix leadership.

ICH · GVP · CIOMS

• Belgium-Wavre
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, benefit-risk assessment, regulatory periodic reports and RMPs, and contributes to safety strategy within a global cross-functional matrix. Involves presenting complex safety issues to senior governance committees and mentoring matrix colleagues.

ICH · GVP · CIOMS

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Leads the global development of a medicine from clinical Proof of Concept to approval in first major markets, acting as the single point of accountability. Builds and directs a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, and owns the asset budget and resourcing plan. Hybrid role requiring at least two days per week on-site at a US or UK GSK site.

• Waltham, United States
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Leads the global development of a medicine from clinical Proof of Concept through first major-market approval, acting as the single point of accountability. Builds and directs a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, and owns the asset's strategy, budget and governance decisions.

• London
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Leads the global development of a medicine from clinical Proof of Concept to approval in first major markets, acting as single point of accountability. Builds and directs a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, driving strategy, governance and go/no-go decisions. Hybrid role with at least two days per week on-site.

• Waltham, United States
• Hybrid
• £188,100 – £313,500 pa
• Director

Leads model-informed drug development for oncology programs, defining and executing model-based strategies from late discovery through lifecycle management. Conducts population PK, exposure-response, simulation-based trial design and dose selection, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis. Presents to governance boards and regulators and works across matrix teams on small molecules, biologics and antibody drug conjugates.

NONMEM · R

• London
• Hybrid
• £119,250 – £198,750 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within Oncology Translational Medicine's Clinical Pharmacology Modelling and Simulation group, working across small molecules, biologics and antibody drug conjugates.

NONMEM · R

• Belgium-Wavre
• Hybrid
• €119,250 – €198,750 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis to small molecules, biologics and antibody drug conjugates. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

NONMEM · R

• USA - Pennsylvania - Upper Providence
• Hybrid
• US$188,100 – US$313,500 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work across small molecules, biologics and antibody drug conjugates, applying AI/ML and quantitative systems pharmacology methods. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

NONMEM · R

• Durham Blackwell Street
• Hybrid
• US$188,100 – US$313,500 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within a matrixed Clinical Pharmacology Modelling and Simulation group working across small molecules, biologics and antibody drug conjugates.

NONMEM · R